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The novel adenylate cyclase activator forskolin 
caused rapid and high intracellular accumulation of 
cyclic AMP in a floating skin (epidermal) slice system. 
Increased cAMP levels were also detected in the media. 
Addition of a phosphodiesterase inhibitor to forskolin-
containing medium caused only a slight increase in the 
intracellular cAMP level and forskolin itself did not 
inhibit phosphodiesterase activity. Ka of forskolin for 
epidermal ·adenylate cyclase was about 2-3 x 10-5 M. 
This forskolin activation was rapidly reversed after 
washing. The forskolin stimulation (Ka 5 x 10-5 M) was 
also found when tested with an epidermal membrane 
preparation which contained the catalytic unit of aden-
ylate cyclase but lacked either the GTP or receptor 
stimulation. With the epidermal slice system, the com-
bination of forskolin and epinephrine (or histamine) 
stimulated adenylate cyclase synergistically. The data 
suggest that forskolin activates not only the catalytic 
unit but also the nucleotide regulatory protein or the 
receptor-regulatory protein complex of the adenylate 
cyclase system. The cAMP accumulation caused by for-
skolin produced a dose-dependent mitotic inhibition of 
epidermal cells in an in vitro outgrowth system. This 
inhibitory effect was reversible 48 h after washing out 
the forskolin. · 
Forskolin is a novel diterpene isolated from the roots of 
Coleus forskohlii [1). Although t he therapeutic use of extracts 
from plants of a related fam ily was described in ancient Hindu 
medical texts, the isolation and identification of fo rskolin as a 
unique adenylate cyclase activator are only recent events [1-
3]. As far as t he mechanism of action is concerned, forskolin 
has been reported to activate directly the catalytic unit of the 
adenylate cyclase system [3,4]. The latest report [5] suggests 
a n additiona l mechanism, such as participation of the nucleo-
tide regulatory protein of the adenylate cyclase unit for full 
activation. 
The action of forskolin on the adenylate cyclase system of 
different cells and tissues has been reported [2-10] but its 
action on the skin adenylate cyclase system has not yet been 
described. Our laboratory has reported on various surface re-
ceptor-adenylate cyclase complexes and their possible relation-
ship to psoriasis [11- 15]. Since the {3-adrenergic-cyclic AMP 
system is defective in psoriasis lesions, any drug or chemical 
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Abbreviations: 
C: catalytic unit 
IBMX: 3-isobutyl-1-methylxanthine 
HE PES: N-2-hydroxyethylpiperazine-N' -2-ethanesu lfon ic acid 
N: nucleotide regulatory protein 
R: receptor site 
that increases the cAMP level in skin may have potential 
therapeutic value. The fact that forskolin is effective in intact 
(unhomogenized) t issues [3,5,9,10] further encouraged us to use 
a simple epidermal slice system in addition to the membrane 
preparation to s tudy its action. 
MATERIALS AND METHODS 
Materials 
[2,8-3H]cAMP (sp act 36.4 Ci/ mmol) was purchased from New 
England Nuclear (Boston, Massachusetts) , [a -32P]ATP (sp act 400 Ci/ 
mmol) from Amersham (Arlington Heights, Illinois), cAMP radioim-
munoassay kit from Collaborative Research, Inc. (Waltham, Massa-
chusetts), and forskolin from Calbiochem (LaJolla, California). All 
other chemicals used were of the highest grade available. 
Methods 
Skin slices (approximately 80% epidermis) were taken from the 
backs of domestic pigs using a keratome with the cutting blade adjusted 
to 0.2 mm or 0.3 mm. The skin slices were cut into 5 X 5 mm squares 
at 4 ·c and floated keratin layer up on Hanks' balanced salt solution. 
After preincubation for 30 min at 37•c, the squares were incubated in 
forskolin and other chemicals. After incubation, they were frozen 
between pieces of dry ice to stop the reaction and cAMP contents were 
measured by radioimmunoassay [16] with inicromodification [17]. 
When cAMP levels in the epidermis were high, we omitted the acety-
lation step of the radioimmunoassay. 
Crude membrane preparations were obtained by homogenization 
with an all glass homogenizer for 3 min in 50 mM HEPES buffer (pH 
8.0) with 0.1 M EDTA and 1 mM MgCb. The homogenate was centri-
fuged at 20,000 g for 20 min and the membrane preparation was washed 
3 times by recentrifugation. The adenylate cyclase activity was assayed 
by slight modification [15] of Salomon's method [18]. which is based 
on the 2-step chromatographic separation of [32P]cAMP. Protein was 
measured by the method of Lowry eta! [19] with human serum albumin 
as a standard. Phosphodiesterase assay was as previously described 
[20] . 
The basic procedures for the explant culture of pig skin were essen-
tially those for mouse skin [21 ] with adaptation to pig skin [22-24]. In 
short, keratome-slice epidermis was cut into 2-mm squares. The 2 rum-
square explants were allowed to attach to glass coverslips in air for 15 
min. RPM! medium containing antibiotics and 10% fetal calf serum 
was then added to each culture and the cultures were allowed to grow 
for 4 days. Cultures with good growth (>300 JLID from the explant) on 
at least 3 sides were then transferred to RPMI medium containing 5% 
dialyzed fetal calf serum, antibiotics, and nucleosides for testing the 
effects of various forskolin concentrations. They were grown for 4 h in 
the presence of colchicine (0.1 !Lg/ml), fixed in alcoho l, stained with 
hematoxylin, and the number of mitoses counted. 
RESULTS 
Experiments with Epidermal Slices 
The incubation of pig skin squares with forskolin caused 
marked stimulation of epidermal adenylate cyclase (Fig 1). The 
cAMP accumulation occurred in both t he t issue and medium. 
The intracellular cAMP levels reached 300 pmol/mg protein 
after 45-min incubation and the levels in the medium were over 
100 pmoljmg protein after 1-h incubation. There was, however, 
a delay in transference of cAMP from the tissues to the medium. 
After 10 min of incubation, cAMP in the medium that had 
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FIG 1. Time course of the effect of forskolin (150 JLM) on the 
intracellular (0- 0) and medium (0- 0) cAMP levels. Details of 
experimental conditions are described in Materials and Methods. Intra-
cellular cAMP levels are averages ± SE of 4 determinations. Medium 
cAMP levels are averages of 2 determinations. 
leaked from the tissues was minimal while the intracellular 
cAMP level had reached over 100 pmoljmg protein. 
To rule out the possibility that the cAMP increase was due 
to an inhibition of its breakdown rather than activation of 
adenylate cyclase, the effect of a phosphodiesterase inhibitor, 
3-isobutyl-1-methylxanthine (IBMX), was tested. Fig 2 shows 
time courses of the forskolin activation in the presence and 
absence of IBMX. The addition of IBMX caused only a mini-
mal additional stimulatory effect. 
In order to examine a direct inhibitory effect of forskolin on 
phosphodiesterase, we measured phosphodiesterase activity in 
epidermal homogenates with and without forskolin. Fig 3 shows 
that forskolin (100 p.M) did not have an inhibitory effect on the 
low Km phosphodiesterase (cAMP concentration at 1p.M). This 
was also true at the high K.n (cAMP concentration at 100 p.M, 
data not shown). Forskolin was also not inhibitory to a com-
mercial phosphodiesterase preparation (Boehringer) . 
Fig 4 shows the concentration curve for forskolin activation 
of adenylate cyclase. This activation by forskolin was dose-
dependent with a maximal response occurring at 100 p.M and 
an apparent Ka value for cAMP at 20- 30 p.M. This activation 
was reversible (fig 5). When the epidermal slices were incubated 
for 45 min with forskolin (150 p.M) and then transferred to 
plain Hanks' balanced salt solqtion medium at 37°C, the cAMP 
level in the epidermis decreased very quickly. However, even at 
2 h after the transfer, the cAMP level in the epidermis was still 
higher than the basal level (6 pmol/mg protein vs the basal 
level of 1 pmol/mg protein). 
To examine the effects of a receptor stimulator with forsko-
lin, we incubated epinephrine or histamine with forskolin . Since 
the cAMP increase caused by epinephrine or histamine is 
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FIG 2. Effects of IBMX (1 mM) on forskolin stimulation: forskolin 
(150 JIM) (0-0), forskolin + IBMX (e- e). Data are averages ± SE 
of 4 determinations. 
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FIG 3. Phosphodiesterase assay with forskolin (100 JIM) (0- 0) or 
with IBMX (100 11M) (L'c. - L'c.) or control (0-0). Skin homogenate (14 
1-'g) was used for this assay. cAMP concentration was 1 J-<M for low Km 
enzyme. 
transient and reaches a peak by 5 min, we chose a 3-min 
incubation period. The concentrations of stimulators were at 
maximum stimulatory doses to examine the possible additive 
effects. As shown in Table I , the combination of forskolin and 
epinephrine yielded a synergistic effect which was much more 
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FIG 4. Stimulation of epidermal adenylate cyclase by various for-
skolin concent rations. Detai ls of experimenta l condi tions are described 
in Materials and Methods. Incubation t ime for forskolin activation was 
10 min. Data are averages of 2 different ski n slices in duplicate for 
each assay. 
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FIG 5. Reversal of the effect of forskolin. After forskolin (150 I'M ) 
st imulat ion for 45 min , skin slices were extensively washed and t rans-
fe rred to plain Hanks' balanced salt solution at 37•c. Data are averages 
of 2 different skin slices in duplicate for each assay. 
than the mathematical sum of the two separately, as did the 
combination of forskolin and histamine. The synergistic effect 
of ep inephrine and forskolin was partially, but not completely, 
inhibited by the specific {3-adrenergic blocker, propranolol (Ta-
Vol. 81, No. 3 
ble II). Propranolol itself had a slight addit ive effect to forskolin 
activat ion. A specific histamine (H2) blocker, metiamide, had 
no effect on forskolin activation nor on forskolin synergism 
when combined with epinephrine. 
Experiments with Epidermal Homogenates 
To examine a direct action of fors kolin on the catalytic unit 
of the adenylate cyclase system, a crude membrane fraction 
was prepared by a glass-glass homogenization of ep idermal 
slices. With this preparation, in which t he guanine nucleotide 
stimulation of t he adenylate cyclase system was no longer 
demonstrable, forskolin showed consistent stimulation of the 
catalytic uni t, i.e., the cAMP increases were both time- and 
dose-dependent. The time course showed an increase for t he 90 
min thus far tested (with a linear rate up to 60 min). Forskolin 
activation of adenylate cyclase at different concent rations with 
the membrane preparation was nearly identical to the concen-
tration curve obtained with epidermal slices (data not shown). 
An apparent Ka value for cAMP was 5 X 10- 5 M. In one 
membrane preparation we compared the degree of stimulation 
due to forskolin (100 JIM) , guanyl-{3, -y-imidodiphosphate (100 
JIM) , sodium fluoride (10 mM), and epinephrine (50 JIM) at their 
max imum stimulatory concentrations. Only fo rskolin and so-
dium fluoride stimulated the membrane preparation to 1100% 
and 450% respectively and the simultaneous addition of both 
forskolin and sodium fluoride did not exceed the 1100% st im-
ulatio n due to forskolin a lone. 
Experiments with Epidermal Explant Outgrowth Culture 
System 
Fig 6 shows t he effects of a 4-h exposure to forskolin on 
epidermal cell mitoses. Dose-dependent inhibit ion of mitoses 
down to a concentration of 1 x 10- 6 M was seen. The reve rsal 
of this inhibit ion was tested, and Fig 7 shows complete recovery 
of mitotic figu res at 48 h after t he washing. It is of interest t hat 
during t he first 4 h after removal of t he fo rskolin , mitotic 
inhibition continued to increase . 
TABLE I. The combinations of forsholin and epinephrine or histamine 
on the epidermal adenylate cyclase cAMP level 
Addition 
None 
Forskolin (150 I'M) 
Epinephrine (50 I'M) 
Histamine (550 ,uM) 
Forskolin + epinephrine 
Forskolin + histamine 
Forskolin + epinephrine + hista-
mine 
cAMP level 
(pmol/ mg protein for 3-min incuba-
tion) 
<1.0 
40.7 ± 2.5 
14.5 ± 2.4 
8.0 ± 1.0 
90.3 ± 6.9 
67.3 ± 8.6 
102.5 ± 14.9 
a Details of experimental condit ions a re described in Materials and 
Methods. T he skin slices were incubated for 3 min. T he values shown 
represent averages + SE of 4 determinations. 
TABLE II. The effects of specific blockers on forshol(n-stimulated 
adenylate cyclase 
Addition 
None 
Forskolin (150 I'M) 
Forskolin + propranolol (1 mM) 
Forskolin + metiamide (1 mM ) 
Forskolin + epinephrine (50 ,uM ) 
Forskolin + epinephrine + propran-
olol 
Forskolin +epinephrine+ metiam-
ide 
cAMP level 
(pmol/mg protein fo r 3-min incuba-
tion) 
<1.0 
31.6 ± 12.9 
64.0 ± 5.6 
41.3 ± 7.7 
152 ± 15.4 
107 ± 12.3 
f79 ± 18.7 
a The values shown represent averages + SE of 5 determinat ions. 
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FIG 6. Inhibition of epidermal cell mi tosis by forskolin. Mitotic 
index shown in the ordinate is the number of colchicine-arrested 
mitoses seen per 1000 cells in culture. The abscissa indicates concen-
t rations of forskolin added in a log scale. Each point represents an 
average from 10 outgrowth cultures ± SE. Mitotic figures (numbers of 
mitoses per culture) also yielded essentially the same curve (data not 
shown ). The control mi totic index (in the absence of fo rskolin) was 
23.7 ± 2.8. 
DISCUSSION 
Forskolin is a extremely potent and unique activator of 
epidermal adenylate cyclase . T he int racellula r cAMP accumu-
lation caused by fo rskolin was much different from that caused 
by stimulators of cell surface receptors such as epinephrine 
[11], histamine [12], prostaglandin E [13], and adenosine [14]. 
The cAMP accumulation caused by forskolin was ext remely 
high (up to 300 pmol/ mg protein) and persisted fo r 60 min, 
whereas t he cAMP accumulation caused by t he stimulators 
noted above was usually less t han 20 pmol/ mg protein and 
t ransient with a peak at 5 min . When the phosphodiesterase 
inhibitor (IBMX) was added to t he medium wit h t he above 
stimulators, t he cAMP level reached a much higher level (up 
to 150 pmol/ mg protein), but persisted for only lO to 20 min 
and decreased t hereafter [11 ,12]. However, IBMX, when added 
to the forskolin -containing medium (Fig 2), caused only a 
minimal additional stimulatory effect . The fact that forskolin 
does not inhibit phosphodiesterase (Fig 3) indicates its direct 
action on adenylate cyclase as a stimulator. The forskolin 
stimulation is reversible after washing and this is in cont rast 
to cholera toxin action on skin s lices [15] which is irreversible 
and requires a lag time (1 h) for activat ion of adenylate cyclase 
in the skin slices (15]. 
What is t he mechanism of t his stimulation? The adenylate 
cyclase system is composed of at least 3 components, a receptor 
site (R) , a nucleot ide regulatory protein (N) , and a catalytic 
unit (C). Hormones or neurotransmitters bind to t heir specific 
Rand subsequently activate N and C [25-27]. Since it stimu-
lates cAMP production in epidermal homogenates (C) which 
cannot be activated by guanine nucleotides, obviously it must 
activate t he catalytic unit directly. The result is compatible 
wit h studies on other mammalian t issues [3,4] which have 
shown t he direct stimulation of solubilized C as well as of a 
variant, S49 lymphoma cells which lack N . In addition to t he 
direct action , however, another mechanism has recent ly been 
proposed, i. e., Darfler et al [5] reported t hat full stimulation of 
t he adenylate cyclase system in wild type S49 cells was due to 
t he st imulation of C and potent iation of hormone-mediated 
response required an intact N. Their data suggested that fo r-
skolin altered t he inte raction of N with both Rand C. Our data 
with epidermal slices have shown that the combinations of 
epinephrine and forskolin, or of histamine and fo rskolin stim-
ulated adenylate cyclase synergistically (T able I). The syner-
gistic effects can arise when two agents act at different (perhaps 
sequent ial) sites along a pathway and hence effects are mult i-
plicative and not merely addit ive. Since N has two functional 
components [28-30] it is reasonable to assume that t he addi-
t ional activating site is a complex form of R and N , or t hat of 
N and C. 
Thus fo rskolin activat ion of the adenylate cyclase system 
has been shown in all mammalian t issues t hus far tested [2-
10] . Both t he potency and mechanisms of stimulation appear 
to be common to all. Membrane preparations of rat cerebellum 
striatum, cortex, heart, and liver exhibited 2- to 4-fold activa-
tion by sodium fluoride and 8- to 15-fo ld activation by forskolin, 
but t hose from skeletal muscle, adrenal, pancreas, lung, and 
stomach showed lesser activation by forskolin than the acti-
vation by sodium fluoride. Our data indicate t hat t he epidermis 
belongs to the former group (sodium fluoride < fo rskolin). 
One of the unique actions of forskolin is its abili ty to stimu-
late in intact cells and organs such as S49 cells [ 4,5], platelets 
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FIG 7. Reversal of forskolin effect in cul ture. Forskolin (1 X 10- 4) 
was washed out after a 4- h exposure and new medium was added. Using 
colchicine, mi totic fi gures were collected at 0- 4 h, 20- 24 h, and 44- 48 
h after the forskolin was removed (0 time). Each point is the average 
of 10 cul tures fo r each control and for each forskolin time period. 
Figu res at 48 h for the washout vs control ex plants are statistically not 
significa nt. Mitotic index also shows an identical curve (data not 
shown). • - • = Forskolin washout, 0-0 = control. 
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[6), adipocytes [7], brain slices [3,10), and epidermis (this 
paper) . This is in contrast to the actions of sodium fluoride and 
guanine nucleotides which do not penetrate intact membranes. 
Perhaps the diterpene structure is suited for membrane pene-
tration, and topical application of forskolin could be an effective 
stimulator of epidermal adenylate cyclase. 
In the explant cul ture system all agents that increase cAMP 
and activate cAMP-dependent protein kinase also cause inhi-
bition of mitotic activity in t he G2 phase of the cell cycle [24,31-
33]. This pharmacologic effect was also shown by forskolin in 
the 4-h assay used. Also, consistent with its biochemical rever-
sal was t he recovery of the cultures after 48 h. Thus, further 
studies with forskolin to counteract hyperplastic skin diseases 
such as psoriasis may be justifiable. 
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